Lacosamide Krka

Lacosamide, the active ingredient in Lacosamide Krka, is an anticonvulsant presented as an oral tablet for oral use. It treats partial‑onset seizures and is used as adjunctive therapy in patients with epilepsy.

GNH USA supplies Lacosamide Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant that acts on neuronal sodium channels to control seizure activity.

Partial‑onset seizures: reduces the frequency and severity of focal seizures. Adjunctive therapy for epilepsy: used in combination with other antiepileptic drugs to improve seizure control. Focal seizures: helps stabilize hyperexcitable neuronal membranes, contributing to overall seizure management.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: mild to moderate upset stomach. - Headache: intermittent or persistent pain. - Fatigue: feeling unusually tired. - Blurred vision: temporary visual disturbances. - Diplopia: double vision in some patients.

Serious or Rare Side Effects: - Cardiac arrhythmias: including atrioventricular block. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hypersensitivity: rash, swelling, or anaphylaxis. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Respiratory depression: especially when combined with other CNS depressants. - Liver enzyme elevation: abnormal hepatic function tests.

Before initiating therapy, certain precautions should be considered to ensure safe use of Lacosamide Krka.

Renal impairment: monitor kidney function and adjust therapy as needed. Hepatic impairment: use with caution and assess liver enzymes regularly. Concomitant CNS depressants: observe for additive sedation or respiratory effects. Pregnancy: risk unknown; discuss potential benefits and risks with a healthcare provider. Driving: avoid operating machinery if dizziness or visual disturbances occur. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Lacosamide can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inducers: may lower lacosamide plasma concentrations. - Class I antiarrhythmic drugs: increased risk of cardiac conduction abnormalities. - Other sodium‑channel blockers: heightened potential for CNS depression.

Moderate Interactions (Monitor Closely): - Alcohol: may amplify dizziness and sedation. - Other antiepileptic drugs: may necessitate dose adjustments. - Warfarin: possible alteration of anticoagulant effect, requiring INR monitoring.